AzTrials
AzTrials

General Population, no Specific ConditionH3SensingNCT06850025

Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach

An observational study of General Population, no Specific Condition, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The first objective of H3Sensing is to investigate outdoor environmental, building, dwelling, situational, and behavioral determinants of objectively assessed personal heat stress over daily movements during warm periods. Read more about this study

Who is it for?
Ages 30 to 64 yearsHealthy volunteers can take part
How many people
180 participants
Where
1 siteFrance
Study dates
25 Feb 2025to 25 Feb 2035
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The study population is a sample recruited through internet advertisement, residing in the Grand Paris, in warmer or cooler areas and in different types of dwellings. Quota sampling is applied in this research.

Who may be able to join

  • Person aged between 30-64 years
  • Person living in the Ile-de-France

Who cannot join

  • Person subject to a legal protection measure (safeguarding of justice, curatorship, guardianship)
  • Person deprived of liberty by a judicial or administrative decision,
  • Person with a major functional limitation affecting their spatial mobility
  • Person unable to complete a questionnaire
  • Known cardiovascular (other than hypertension) or cerebrovascular disease: personal history of myocardial infarction, rhythm disorders or stroke
  • People wearing a pacemaker or other implanted device, due to the risk of interference
Show all 11Show fewer
  • Pregnant or breastfeeding woman
  • Person working night or shift
  • Person with a definite plan to move in the coming months (before the second collection during summer)
  • Person who initially refuses to participate in this second wave of the study
  • Person working outside the Ile de France

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Pierre Louis Institute of Epidemiology and Public Health

    Paris, 75012

    Recruiting

Other trials in France

About this study

Official title: Heat Waves, Urban Heat Islands, and Wellbeing and Health: a Mobile Sensing Approach (H3Sensing)

The first objective of H3Sensing is to investigate outdoor environmental, building, dwelling, situational, and behavioral determinants of objectively assessed personal heat stress over daily movements during warm periods.

The second aim is to investigate how these heat stress determinants and momentary and cumulated heat stress itself are related to physiological indicators of heat stress, sleep, thermal discomfort, and well-being.

Read the detailed description

While the number of heat wave days in France will likely continue to increase over the century, extreme heat is associated with excess mortality and morbidity in urban heat islands. The first objective of H3Sensing is to investigate outdoor environmental, building, dwelling, situational, and behavioral determinants of objectively assessed personal heat stress over daily movements during warm periods. We will explore environmental determinants associated with micro-urban heat islands at an unprecedented level of accuracy; we will assess building and dwelling characteristics associated with in-home heat stress; and we will examine how daily activities (trips, etc.) and practices (how people dress, manage heat at home) contribute to heat stress. The second aim is to investigate how these heat stress determinants and momentary and cumulated heat stress itself are related to physiological indicators of heat stress, sleep, thermal discomfort, and well-being. One hundred eighty (180) participants recruited through internet advertisements will be followed over 4 day periods in March-May and then a second time in June-September 2025. Research assistants will use a detailed assessment sheet (defined from the a priori visit to 10 dwellings) to collect information on building and dwelling characteristics. Participants will carry a smartphone with a GPS receiver and the Eco Emo tracker application permitting to identify their trips and visited places and to collect additional information on these trips (including their access to air conditioned). GPS data will permit to dynamically assess exposures in participants' everyday mobility. To move beyond simplistic assessments of personal heat stress, we will assess it in an ambulatory way considering personal ambient temperature, humidity, wind speed, and radiant temperature combined into the universal thermal climate index. Additionally, a meteorological station will be placed in the bedroom, while sensors measuring solar flux will be installed outdoor on the windows and balcony. Participants will also carry two bracelets for the measurement of physiological parameters (blood pressure, skin temperature, galvanic skin response as a marker of sweating, and heart rate). As part of the VF++ project, core temperature data will be additionally collected in a subsample of participants (e.g., 20 participants). Personal thermal discomfort, well-being, and sleep quality will be self-reported on the smartphone using the Eco Emo tracker application. An a posteriori phone questionnaire will collect detailed information on heat-related practices and health impacts over the observation period. Analyses of short-term effects will use repeated measure models. Investigations of momentary objective heat stress as the outcome will use statistical techniques for complex mixtures to handle the wide set of exposures. Analyses of sleep quality, well-being, and physiological measures as the outcomes will use two complementary designs: fixed-effect analyses of matched observations in the warm and in the cooler periods for the same participants; and participant-level fixed-effect analyses of pooled observations in the warm period. H3Sensing brings together epidemiologists, urbanists, and climate scientists. As research-to-policy translation, experts in urbanism involved in the project will formulate concrete technical recommendations and will identify practical solutions (in a pedagogical document of synthesis) to help urban actors willing to integrate considerations related to urban heat islands in their urbanistic regulations, public policies, and urban planning projects.

Keywords
Heat waves, Urban Heat Islands, Wellbeing, Health, Thermoregulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06850025
Study groupRoleWhat they receive
180 participants from the Grand Paris area180 participants recruited in the Grand Paris area through web and social network advertisements.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ambulatory blood pressure

    Ambulatory blood pressure measured with a bracelet

    Measured: Measurement over 4 days, in two separate waves of 4 days

  2. Skin temperature

    It is measured with a bracelet, in degrees. It provides important information on the interaction of the body with the heat environment.

    Measured: Measurement over 4 days, in two separate waves of 4 days

  3. Accelerometry outcomes: total sleep time, sleep efficiency, and wake after sleep onset

    These three accelerometry outcomes will be derived from a bracelet. Total sleep time is in hours and minutes. Sleep efficiency is a percentage. Wake after sleep onset is in minutes.

    Measured: These outcomes are collected for 5 successive nights in each of the two periods.

Secondary outcomes (1)
  1. Personal heat stress measured with the Universal Thermal Climate Index

    This secondary outcome will be measured with a unique indicator called the Universal Thermal Climate Index. Although it is based on 4 parameters measured with wearable sensors (air temperature, humidity, radiant temperature, and air flow), it is measured in degree Celsius (so with a unique unit).

    Measured: Measured continuously over 2 waves of 4 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2025
  2. Study start25 Feb 2025
  3. Primary completion25 Feb 2027 (estimated)
  4. Study completion25 Feb 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Prospective
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06850025
Sponsor's protocol ID
C22-60
Other IDs
2022-A02108-35
Acronym
H3Sensing
Status last verified
Jul 2026
First submitted
13 Feb 2025
Last updated
31 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of General Population, no Specific Condition, run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Basile Chaix, PhD (00 33 6 68 30 00 55, basile.chaix@iplesp.upmc.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ambulatory blood pressure (time frame: Measurement over 4 days, in two separate waves of 4 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in